Altogether, these results further consolidate a novel mechanism that deubiquitinase USP39 and E3 ligase TRIM26 function in an antagonistic pattern and play key roles in controlling ZEB1 stability to determine the HCC progression. Here, ZEB1 is linked to hepatocellular carcinoma.